BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Prognosis
7 results:

  • 1. Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?
    Vrede SW; Donkers H; Reijnen C; Smits A; Visser NCM; Geomini PM; Ngo H; van Hamont D; Pijlman BM; Vos MC; Snijders MPLM; Kruitwagen R; Bekkers RLM; Galaal K; Pijnenborg JMA
    J Obstet Gynaecol; 2024 Dec; 44(1):2294332. PubMed ID: 38186008
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical cancer.
    Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
    Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
    [No Abstract]    [Full Text] [Related]  

  • 3. Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
    Jiang AG; Cai X
    BMC Cancer; 2022 Jan; 22(1):4. PubMed ID: 34980030
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical cancer.
    Wang Y; Zhang L; Wang B; Cheng Y
    Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.
    Zheng F; Yu H
    Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Endometrial cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and prognosis.
    Joehlin-Price AS; Stephens JA; Zhang J; Backes FJ; Cohn DE; Suarez AA
    Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):438-45. PubMed ID: 26682991
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Plasma D-dimer measurement as a marker of gynecologic tumors: comparison with Ca 125.
    Rella C; Coviello M; De Frenza N; Falco G; Chiuri E; Colavito P; Quaranata M; De Leonardis A
    Tumori; 1993 Oct; 79(5):347-51. PubMed ID: 8116080
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.